{"id":5210,"date":"2018-11-06T12:51:55","date_gmt":"2018-11-06T14:51:55","guid":{"rendered":"https:\/\/mapesolutions.com\/?p=5210"},"modified":"2021-10-26T15:50:16","modified_gmt":"2021-10-26T18:50:16","slug":"disinvestment-in-technology-for-greater-cost-effectiveness","status":"publish","type":"post","link":"https:\/\/mapesolutions.com\/en\/disinvestment-in-technology-for-greater-cost-effectiveness\/","title":{"rendered":"Disinvestment in technology for greater cost-effectiveness"},"content":{"rendered":"

[:pb]The incorporation of technologies <\/a> is a complex process that generally involves high costs for healthcare systems, whether public or private. Not to mention the responsibility for the lives of the population, a fundamental factor for all decision-making in this regard. Therefore, the incorporated technologies need to be eventually re-evaluated and, if this new analysis shows that the drug, equipment, product or service did not reach the expected goals and no longer present health benefits compatible with the expenses spent, it is possible to opt for disinvestment<\/strong>.<\/p>\n

From this decision, it is necessary to reinvest the financial resources applied in the technology used until then. This reinvestment, however, does not necessarily consist in allocating values in a technology that directly replaces the one that was eliminated or restricted, but it can be directed to another area of the health system. The objective of a divestment in a technology, therefore, is to maximize health gains with the available financial resources.<\/strong>. Learn more about the topic.<\/p>\n

Healthcare Technology Performance Assessment (HpTA)<\/h2>\n

The disinvestment and reinvestment processes have as instrument the Healthcare Technology Performance Assessments (HpTA)<\/strong>. Basically, they are the analyzes that the technology goes through after it has already been incorporated. While Healthcare Technology Assessments (HTA)<\/a>, carried out to recommend or not incorporation, are based on clinical and economic studies, HpTA use information from the real world, known as RWE (real world evidence). Among them are data on effectiveness, safety, logistics and acceptance of the healthcare system in practice.<\/p>\n

Disinvestment and reinvestment modalities in healthcare technologies<\/h2>\n

The healthcare technologies that undergo this type of reassessment are those that have become obsolete over time, that have some security flaw or that show signs of not being so interesting from the point of view of cost-effectiveness. If these problems are confirmed with the realization of HpTA, the technology may no longer be financed as it was until then, so that the resources spent on it are applied to other technologies, which bring greater benefit to the population and greater return on investment. But that doesn’t necessarily mean abandoning the technology altogether. Disinvestment can take place in the following modalities:<\/p>\n